Coordinating Center for Canine Immunotherapy Trials and Correlative Studies (U24)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) will support a coordinating center for a network of cooperative agreements (see U01 FOA RFA-CA-17-001) that will conduct clinical trials in pet dogs with spontaneous tumors and perform laboratory correlative studies associated with the clinical trials. This FOA will work with the NCI Comparative Oncology Program (COP) of the NCI's Center for Cancer Research as an integral component and will provide statistical support; assist with the development and standardization of clinical protocols and laboratory immune monitoring assays; assist with the implementation of clinical studies in immunotherapy and combination agents including accrual to the trials; manage clinical and correlative data from all U01 sites and their collaborators including immune-related adverse events; facilitate the sharing of agents, specimens, and data; and create an ad hoc steering committee of required expertise--both inside and outside the U01 network, including the PD/PIs of the U01s, representatives of the COP and the NCI Program Official--to ensure that the goals of the network are accomplished.


  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • Application Due Date(s): March 7, 2017

RFA-CA-17-002 Expiration Date March 8, 2017

Agency Website



Amount Description

Budgets for direct costs may not exceed $350,000 per year.

The maximum project period is 5 years.

Funding Type





Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

March 7, 2017